You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK):中核高通與德國ITM簽署合資公司合作協議
中國同輻(01763.HK)公佈,中核高通與德國ITM簽署合資公司合作協議,標誌着國內首個致力於國產新一代診療一體化醫用同位素供應的中德合資公司即將成立。 中核高通是中國同輻旗下所屬控股公司,以放射性同位素產品的開發、生產和銷售爲主業,兼營進出口貿易、貨物運輸。ITM是ITM Isotopen Technologien Munchen AG的全資子公司,後者是一家致力於開發、生產和全球供應腫瘤精準醫療的創新診斷和治療用放射性核素及放射性藥物公司。 中德合資公司基於雙方2019年簽署的68Ge-68Ga發生器和無載體生產和銷售技術許可協議而組建,是技術轉移項目整體進程中又一個極富意義的重要裏程碑事件,是中國同輻與德國ITM公司在醫用同位素及新一代診療一體化藥物應用推廣領域合作的進一步深化,加速爲中國市場提供基於專利技術和國際認可質量標準的新型放射性核素及服務。該合資公司將爲中國癌症患者提供高質量的、經濟上可持續的治療方案,推進中國核醫學和國民健康事業的發展。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account